Skin tests using tuberculin and dinitrochlorobenzene (DNCB) in extremity sarcoma patients correlate with disease prognosis. A positive DNCB test indicated a more advanced disease stage and poorer survival outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: